Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$0.4 - $0.63 $161,333 - $254,100
-403,334 Reduced 24.96%
1,212,524 $521,000
Q2 2022

Aug 15, 2022

BUY
$4.21 - $11.15 $940,695 - $2.49 Million
223,443 Added 16.05%
1,615,858 $7.47 Million
Q4 2021

Feb 14, 2022

BUY
$15.37 - $22.5 $18.6 Million - $27.3 Million
1,212,524 Added 674.03%
1,392,415 $23.8 Million
Q1 2021

May 17, 2021

BUY
$24.23 - $27.06 $4.36 Million - $4.87 Million
179,891 New
179,891 $4.51 Million

Others Institutions Holding TIL

About Instil Bio, Inc.


  • Ticker TIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,694,000
  • Market Cap $2.82B
  • Description
  • Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...
More about TIL
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.